RGO.F
Regeneron Pharmaceuticals, Inc.
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
702.80
▼ 13.00 (1.82%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
702.80
Prev close
715.80
Day high
702.80
Day low
702.80
Volume
1
Market cap
$72.36B
P/E (TTM)
20.32
52W range
471.70 – 719.00
Day trading desk
Gap from prior close
-1.82%
Prior close 715.80
VWAP
702.80
0.00% from price
Relative volume
0.17×
Quiet session
Session range
—
702.80 – 702.80
Position in range
—
—
ATR (14D)
8.06
1.15% of price
Prior day high
715.80
PDH
Prior day low
715.80
PDL
Bid / ask spread
—
Quote not published
Session volume
1
Avg 6
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.22%
+2.6%
1M
+24.24%
+20.5%
3M
+28.25%
+25.2%
6M
+8.09%
-3.0%
YTD
+5.40%
-6.9%
1Y
+36.47%
+16.5%
3Y
-7.95%
-82.1%
5Y
+450.40%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on RGO.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
2.08M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 10, 26 | GUARINI KATHRYN PH.D. Director |
CONVERSION | 400 | $287.75K | Direct |
| Aug 10, 26 | ZOGHBI HUDA Y Director |
CONVERSION | 800 | $301.35K | Direct |
| Aug 10, 26 | ZOGHBI HUDA Y Director |
SELL | 800 | $640.00K | Direct |
| Aug 10, 26 | GUARINI KATHRYN PH.D. Director |
SELL | 400 | $320.00K | Direct |
| Jul 2, 26 | RYAN ARTHUR F. Director |
SELL | 200 | $130.03K | Direct |
| May 1, 26 | RYAN ARTHUR F. Director |
SELL | 100 | $70.52K | Direct |
| Apr 1, 26 | RYAN ARTHUR F. Director |
SELL | 100 | $77.73K | Direct |
| Mar 2, 26 | RYAN ARTHUR F. Director |
SELL | 100 | $78.55K | Direct |
| Feb 19, 26 | ZOGHBI HUDA Y Director |
CONVERSION | 1.64K | $617.02K | Direct |
| Feb 19, 26 | ZOGHBI HUDA Y Director |
SELL | 1.64K | $1.28M | Direct |
| Feb 9, 26 | PITOFSKY JASON Officer |
CONVERSION | 1.00K | $492.00K | Direct |
| Feb 9, 26 | RYAN ARTHUR F. Director |
SELL | 100 | $77.85K | Direct |
| Feb 9, 26 | PITOFSKY JASON Officer |
SELL | 2.04K | $1.59M | Direct |
| Jan 7, 26 | BASSLER BONNIE L Director |
CONVERSION | 1.50K | $561.18K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BROWN MICHAEL S |
Director | 12.87K | Stock Award(Grant) |
FENIMORE CHRISTOPHER R |
Chief Financial Officer | 21.80K | Stock Award(Grant) |
LAROSA JOSEPH J |
General Counsel | 42.31K | Stock Award(Grant) |
MCCOURT MARION E |
Officer | 15.57K | Stock Award(Grant) |
MURPHY ANDREW J |
Officer | 56.44K | Stock Award(Grant) |
RYAN ARTHUR F. |
Director | 17.30K | Sale |
SCHLEIFER LEONARD S |
Chief Executive Officer | 687.98K | Conversion of Exercise of derivative security |
SING GEORGE LOUIS |
Director | 33.16K | Stock Award(Grant) |
VAN PLEW DANIEL P |
Officer | 37.73K | Stock Award(Grant) |
YANCOPOULOS GEORGE D |
President | 1.13M | Conversion of Exercise of derivative security |
Fundamentals
Market cap$72.36B
Enterprise value$64.89B
Revenue (TTM)$15.53B
Gross profit$6.91B
EBITDA$4.70B
Net income$4.33B
EPS (TTM)$34.58
Free cash flow$3.07B
Total cash$7.99B
Total debt$2.71B
Book value / share$270.57
Shares outstanding101.14M
Float95.79M
Short % of float—
Dividend yield0.46%
Beta (5Y)0.19
Valuation & profitability ratios
Trailing P/E20.32
Forward P/E15.92
PEG ratio1.36
Price / sales—
Price / book2.60
EV / revenue4.18
EV / EBITDA13.80
Gross margin44.46%
Operating margin33.11%
Profit margin27.87%
Return on equity14.04%
Return on assets6.53%
Debt / equity8.54
Current ratio3.34
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $14.34B | $14.20B | $13.12B | $12.17B | +1.0% |
| Operating revenue | $13.64B | $13.69B | $12.58B | $11.81B | -0.3% |
| Cost of revenue | $2.10B | $1.97B | $1.82B | $1.56B | +6.6% |
| Gross profit | $12.24B | $12.23B | $11.30B | $10.61B | +0.1% |
| Research & development | $5.85B | $5.23B | $4.63B | $3.85B | +11.8% |
| Selling, general & admin | $2.70B | $2.95B | $2.63B | $2.12B | -8.6% |
| Total operating expense | $8.54B | $8.24B | $7.25B | $5.87B | +3.6% |
| Operating income | $3.70B | $3.99B | $4.05B | $4.74B | -7.2% |
| Net interest income | $673.00M | $656.20M | $422.90M | $100.70M | +2.6% |
| Pre-tax income | $5.23B | $4.78B | $4.20B | $4.86B | +9.4% |
| Tax provision | $725.80M | $367.30M | $245.70M | $520.40M | +97.6% |
| Net income | $4.50B | $4.41B | $3.95B | $4.34B | +2.1% |
| Net income to common | $4.50B | $4.41B | $3.95B | $4.34B | +2.1% |
| Basic EPS | 43.07 | 40.90 | 37.05 | 40.51 | +5.3% |
| Diluted EPS | 41.48 | 38.34 | 34.77 | 38.22 | +8.2% |
| EBIT | $5.27B | $4.84B | $4.27B | $4.92B | +9.1% |
| EBITDA | $5.82B | $5.32B | $4.69B | $5.26B | +9.4% |
| Basic shares | 104.60M | 107.90M | 106.70M | 107.10M | -3.1% |
| Diluted shares | 108.60M | 115.10M | 113.70M | 113.50M | -5.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $3.12B | $2.49B | $2.73B | $3.11B | +25.3% |
| Cash & short-term investments | $8.61B | $9.01B | $10.84B | $7.74B | -4.5% |
| Accounts receivable | $5.74B | $6.21B | $5.67B | $5.33B | -7.6% |
| Inventory | $3.20B | $3.09B | $2.58B | $2.40B | +3.7% |
| Total current assets | $18.02B | $18.66B | $19.48B | $15.88B | -3.4% |
| Property, plant & equipment | $5.12B | $4.60B | $4.15B | $3.76B | +11.3% |
| Goodwill & intangibles | $1.26B | $1.15B | $1.04B | $915.50M | +9.5% |
| Total assets | $40.56B | $37.76B | $33.08B | $29.21B | +7.4% |
| Total current liabilities | $4.37B | $3.94B | $3.42B | $3.14B | +10.8% |
| Long-term debt | $1.99B | $1.98B | $1.98B | $1.98B | +0.1% |
| Total debt | $2.71B | $2.70B | $2.70B | $2.70B | +0.1% |
| Total liabilities | $9.30B | $8.41B | $7.11B | $6.55B | +10.7% |
| Retained earnings | $35.80B | $31.67B | $27.26B | $23.31B | +13.0% |
| Shareholder equity | $31.26B | $29.35B | $25.97B | $22.66B | +6.5% |
| Working capital | $13.65B | $14.72B | $16.06B | $12.74B | -7.2% |
| Net tangible assets | $30.00B | $28.20B | $24.93B | $21.75B | +6.4% |
| Shares issued | 139.42M | 137.82M | 134.92M | 132.20M | +1.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $4.50B | $4.41B | $3.95B | $4.34B | +2.1% |
| Depreciation & amortisation | $543.70M | $482.90M | $421.00M | $341.40M | +12.6% |
| Stock-based compensation | $993.70M | $982.80M | $885.00M | $725.00M | +1.1% |
| Change in working capital | $532.60M | -$618.30M | -$94.10M | -$243.30M | +186.1% |
| Operating cash flow | $4.98B | $4.42B | $4.59B | $5.01B | +12.6% |
| Capital expenditure | -$1.21B | -$881.60M | -$926.40M | -$1.62B | -37.7% |
| Investing cash flow | -$629.10M | -$2.47B | -$3.19B | -$3.78B | +74.5% |
| Share buybacks | -$3.97B | -$3.63B | -$2.94B | -$2.53B | -9.3% |
| Dividends paid | -$370.30M | $0 | $0 | — | — |
| Financing cash flow | -$3.72B | -$2.20B | -$1.79B | -$1.01B | -68.8% |
| Free cash flow | $3.77B | $3.54B | $3.67B | $3.40B | +6.4% |
| End cash position | $3.12B | $2.49B | $2.74B | $3.12B | +25.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $4.29B | $3.61B | $3.88B | $3.75B | $3.68B | — | +19.0% |
| Operating revenue | $4.10B | $3.43B | $3.65B | $3.56B | $3.49B | — | +19.3% |
| Cost of revenue | $576.50M | $669.40M | $584.60M | $521.60M | $530.20M | — | -13.9% |
| Gross profit | $3.71B | $2.94B | $3.30B | $3.23B | $3.15B | — | +26.5% |
| Research & development | $1.63B | $1.54B | $1.63B | $1.48B | $1.43B | — | +5.7% |
| Selling, general & admin | $662.10M | $647.70M | $775.00M | $657.80M | $634.20M | — | +2.2% |
| Total operating expense | $2.29B | $2.19B | $2.40B | $2.12B | $2.07B | — | +4.7% |
| Operating income | $1.42B | $744.80M | $898.60M | $1.11B | $1.08B | — | +90.7% |
| Net interest income | $172.30M | $170.60M | $181.10M | $155.80M | $171.20M | — | +1.0% |
| Pre-tax income | $1.53B | $831.20M | $1.04B | $1.76B | $1.52B | — | +83.8% |
| Tax provision | $230.90M | $104.00M | $199.10M | $303.30M | $127.10M | — | +122.0% |
| Net income | $1.30B | $727.20M | $844.60M | $1.46B | $1.39B | — | +78.3% |
| Net income to common | $1.30B | $727.20M | $844.60M | $1.46B | $1.39B | — | +78.3% |
| Basic EPS | 12.62 | 6.99 | 8.21 | — | 13.24 | 7.58 | +80.5% |
| Diluted EPS | 12.23 | 6.75 | 7.86 | — | 12.81 | 7.27 | +81.2% |
| EBIT | $1.54B | $844.10M | $1.06B | $1.78B | $1.52B | — | +82.3% |
| EBITDA | $1.66B | $967.30M | $1.20B | $1.92B | $1.66B | — | +71.9% |
| Basic shares | 102.80M | 104.00M | 102.90M | — | 105.10M | 106.70M | -1.2% |
| Diluted shares | 106.00M | 107.70M | 107.50M | — | 108.60M | 111.20M | -1.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.46B | $2.96B | $3.12B | $2.51B | $2.00B | -17.1% |
| Cash & short-term investments | $7.99B | $8.75B | $8.61B | $8.44B | $7.47B | -8.7% |
| Accounts receivable | $6.57B | $5.73B | $5.74B | $5.69B | $5.61B | +14.6% |
| Inventory | $3.08B | $3.10B | $3.20B | $3.25B | $3.21B | -0.6% |
| Total current assets | $18.45B | $18.21B | $18.02B | $17.98B | $16.86B | +1.3% |
| Property, plant & equipment | $5.46B | $5.27B | $5.12B | $5.00B | $4.84B | +3.7% |
| Goodwill & intangibles | $1.31B | $1.29B | $1.26B | $1.38B | $1.35B | +1.8% |
| Total assets | $41.73B | $40.87B | $40.56B | $40.17B | $38.22B | +2.1% |
| Total current liabilities | $5.53B | $5.11B | $4.37B | $4.43B | $3.67B | +8.3% |
| Long-term debt | $1.99B | $1.99B | $1.99B | $1.99B | $1.99B | +0.0% |
| Total debt | $2.71B | $2.71B | $2.71B | $2.71B | $2.71B | +0.0% |
| Total liabilities | $10.02B | $9.45B | $9.30B | $9.21B | $8.28B | +6.1% |
| Retained earnings | $37.62B | $36.42B | $35.80B | $35.05B | $33.68B | +3.3% |
| Shareholder equity | $31.71B | $31.42B | $31.26B | $30.96B | $29.94B | +0.9% |
| Working capital | $12.92B | $13.10B | $13.65B | $13.56B | $13.19B | -1.4% |
| Net tangible assets | $30.40B | $30.14B | $30.00B | $29.58B | $28.59B | +0.9% |
| Shares issued | 103.14M | 139.72M | 139.42M | 138.02M | 138.02M | -26.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $1.30B | $727.20M | $844.60M | $1.46B | $1.39B | +78.3% |
| Depreciation & amortisation | $123.70M | $123.20M | $145.00M | $136.70M | $135.10M | +0.4% |
| Stock-based compensation | $243.00M | $257.40M | $249.30M | $237.00M | $251.70M | -5.6% |
| Change in working capital | -$649.20M | $36.50M | $5.90M | $625.00M | -$227.90M | -1,878.6% |
| Operating cash flow | $813.00M | $1.08B | $1.17B | $1.62B | $1.14B | -24.6% |
| Capital expenditure | -$291.20M | -$279.50M | -$290.70M | -$244.70M | -$406.80M | -4.2% |
| Investing cash flow | -$92.70M | -$428.90M | $220.30M | -$402.90M | -$1.09B | +78.4% |
| Share buybacks | -$1.18B | -$867.50M | -$1.19B | -$667.00M | -$1.07B | -35.7% |
| Dividends paid | -$96.80M | -$97.80M | -$92.70M | -$91.20M | -$92.60M | +1.0% |
| Financing cash flow | -$1.22B | -$802.20M | -$780.10M | -$717.90M | -$1.13B | -52.7% |
| Free cash flow | $521.80M | $799.40M | $880.00M | $1.37B | $737.60M | -34.7% |
| End cash position | $2.47B | $2.97B | $3.12B | $2.51B | $2.02B | -17.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $4.54B | +21.0% |
| Next quarter | — | — | $4.63B | +19.2% |
| Current year | — | — | $16.92B | +18.0% |
| Next year | — | — | $18.42B | +8.8% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders2.08%
Held by institutions93.44%
Institutions holding1.92K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
697.11
+0.82% from price
SMA 20
665.60
+5.59% from price
SMA 50
601.66
+16.81% from price
SMA 100
595.80
+17.96% from price
SMA 200
618.70
+13.59% from price
EMA 12
688.24
+2.12% from price
EMA 26
656.32
+7.08% from price
EMA 50
626.57
+12.17% from price
RSI (14)
70.3
Overbought
MACD (12,26,9)
31.92
Hist 1.32
ATR (14)
8.06
1.15% of price
Realised vol 30D
30.0%
Annualised
Bollinger upper
744.98
20, 2σ
Bollinger lower
586.23
20, 2σ
50 / 200 cross
Death
601.66 vs 618.70
Trend bias
Above 200
+13.59%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.08
Less volatile than market
Correlation to SPY
-0.03
Largely independent
Realised vol 30D
30.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-27.3%
Peak to trough
Max drawdown 5Y
-61.0%
Peak to trough
ATR 14
8.06
1.15% of price
Beta (reported)
0.19
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 17, 26 | Leerink Partners | MAINTAINED | Market Perform | Market Perform |
| Aug 3, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Aug 3, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jul 31, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Jul 31, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 31, 26 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
| Jul 31, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 31, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jul 21, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jul 9, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Jul 8, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 7, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
Dividends & splits
Forward rate$3.25 / yr
Forward yield0.46%
5-year avg yield—
Payout ratio9.01%
Ex-dividend dateAug 18, 2026
Next pay date—
Last split—
Split date—
Headlines
Hindustan Coca-Cola Beverages Certified as a Top Employer in India for 2026 by Top Employers Institute
PR Newswire · 10m ago
Asian shares mostly decline as bond market pressure mounts
Associated Press · 10m ago
INDONESIAN HEALTHCARE TRAVEL TO MALAYSIA HITS RECORD RM2.2 BILLION AS MHX RETURNS TO YOGYAKARTA
PR Newswire · 16m ago
BW Offshore: Second quarter and first half results 2026
GlobeNewswire · 16m ago
Sampo plc’s share buybacks week 34/2026
GlobeNewswire · 16m ago
Elon Musk's Tesla Has 'Massive Advantage' Before Selling Optimus in the Market, Says This Analyst — Crypto Prediction Market Weighs 2026 Launch Odds
Benzinga Prediction Markets · 16m ago
SPCX Stock Slides Overnight: Musk Maps Falcon Wind-Down For Starship — Rare ‘Sell’ Call Sees 27% Downside
Stocktwits · 18m ago
UAB “Atsinaujinančios energetikos investicijos” Starts Second Tranche Offering Of Notes Under The EUR 25 million Bonds Programme; The First Tranche Final Terms Of Notes Were Adjusted
GlobeNewswire · 22m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.